What is Parkinson

Parkinson’s disease is a progressive neurodegenerative disorder primarily affecting the nervous system, characterized by a loss of dopamine-producing neurons that leads to significant motor and non-motor impairment.

Understanding the Condition

At its core, Parkinson’s disease involves the death of nerve cells in the substantia nigra, an area of the brain responsible for producing dopamine. Dopamine acts as a chemical messenger that coordinates smooth, purposeful movement. As these cells die, dopamine levels drop, resulting in the classic motor symptoms such as bradykinesia (slowness of movement), resting tremors, muscle rigidity, and postural instability. While primarily a movement disorder, Parkinson’s disease also impacts the autonomic nervous system, often leading to non-motor symptoms like sleep disturbances, cognitive changes, and mood fluctuations.

Prevalence and Demographics

Parkinson’s disease is the second most common neurodegenerative disorder globally. While it is often associated with aging—typically appearing after age 60—young-onset cases can occur. It affects both men and women, though research consistently shows a slightly higher prevalence in men. Because it is a global condition, it does not discriminate by geography, though access to specialized neurological care remains a critical factor in patient outcomes.

Pathophysiology and Differentiation

The hallmark of Parkinson’s disease is the accumulation of Lewy bodies, which are abnormal aggregates of a protein called alpha-synuclein within the brain. This distinguishes it from other "parkinsonian" syndromes, such as Multiple System Atrophy or Progressive Supranuclear Palsy. While those conditions share similar symptoms like shuffling gait or speech impairment, they often progress differently and respond less consistently to standard treatments like Levodopa. Identifying these differences is a crucial part of the diagnostic process for neurologists.

Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD)


• Orphanet: The portal for rare diseases and orphan drugs


• The Michael J. Fox Foundation for Parkinson's Research


• OMIM (Online Mendelian Inheritance in Man)